Biopol Chemicals logo

Biopol Chemicals financials and balance sheet

NSE: BIOPOLChemicals & Petrochemicals

Last close ₹42.10down ₹3.75 (8.18%)

Share price at the NSE close on 23 Oct 2026. Previous close ₹45.85.

Range of traded prices from listing on 13 Feb 2026 to 23 Oct 2026
₹39.50Low, 3 Sep 2026₹133.75High, 15 May 2026
Market cap
₹45 Cr
P/E
5.1
P/B
0.9
Dividend yield
Nonesince listing in Feb 2026
ROE
18.0%
Debt to equity
0.17
Volume, NSE
22,80068.4% delivered

1 year at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Biopol Chemicals annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue81
  2. Materials and goods−63
  3. Employee costs−1.8
  4. Other expenses−2.8
  5. Operating profit13
  6. Depreciation−0.1
  7. Other income+0.2
  8. Finance costs−1.5
  9. Profit before tax12
  10. Tax−3.1
  11. Net profit9.0

What the company owns

  • Receivables₹28 Cr
  • Plant, investments and other assets₹22 Cr
  • Inventory₹20 Cr
  • Cash and bank₹1 Cr

What pays for it: net worth and liabilities

  • Net worth₹50 Cr
  • Borrowings₹8 Cr
  • Owed to suppliers₹6 Cr
  • Other liabilities₹5 Cr

Profit and loss

Standalone, ₹ crore, years to March.Biopol Chemicals half-yearly results

₹ croreMar 2026Filed 30 Apr
Revenue from operations81.1
67.7
Materials and goods bought63.1
Employee costs1.8
Other expenses2.8
Operating profit before depreciation13.4
Operating margin16.6%
Materials, % of revenue77.8%
Employee costs, % of revenue2.2%
Other expenses, % of revenue3.5%
Depreciation and amortisation0.1
Operating profit after depreciation13.4
Other income0.2
Finance costs1.5
Profit before tax12.1
3.1
Net profit9.0
Net margin11.1%

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2026Filed 30 Apr
49.9
Share capital10.8
Reserves39.1
8.5
14.7
5.1
Total assets69.8
14.8
55.0
Net debt7.9
Borrowings are counted again inside the liabilities due within a year and after a year.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2026Filed 30 Apr
−12.8
−12.4
−26.1
Receivables−11.1
Inventories−7.8
Payables−2.2
Other working capital−5.0
Tax paid−0.3
Capital spending14.1
Free cash flow−26.8
−14.5
26.7
Dividends paid0.0
Shares issued27.4
Net change in cash−0.6
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2026Filed 30 Apr
Earnings per share₹10.83
Diluted earnings per share₹10.83
Book value per share₹63.10
Shareholder yield−26.1%
Market cap at the year end (₹ crore)105

Ratios

Standalone, years to March.Biopol Chemicals PE ratio and valuation

RatioMar 2026Filed 30 Apr
Return on equity18.0%
Return on capital employed22.9%
Cash conversion−142.3%
Interest cover8.8
Debt to equity0.17
Receivable days125
Inventory days113
Payable days37
Cash conversion cycle, days201
Working capital days194
Asset turnover1.16
Assets per rupee of net worth1.40
Sales per rupee of plant5.70
Capital spending to depreciation143.23

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
12.9%
Cash from operations against operating profit
−94.9%

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ croreLatest year
Cash from operations−12.8
Cash from investing−14.5
Cash from financing26.7
Capital spending14.1
Dividends paid0.0
Shares issued for cash27.4
Borrowings raised7.6
Borrowings repaid6.8

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2026
Effective tax ratePublished threshold 17.16 per cent25.58
Tax charged less tax paid, % of profitOur threshold 10 percentage points23.18
A threshold marked as ours has no published figure; it is the line we read the check against.